ATE367392T1 - Indolderivate mit verbesserter antipsychotischer wirkung - Google Patents
Indolderivate mit verbesserter antipsychotischer wirkungInfo
- Publication number
- ATE367392T1 ATE367392T1 AT04741649T AT04741649T ATE367392T1 AT E367392 T1 ATE367392 T1 AT E367392T1 AT 04741649 T AT04741649 T AT 04741649T AT 04741649 T AT04741649 T AT 04741649T AT E367392 T1 ATE367392 T1 AT E367392T1
- Authority
- AT
- Austria
- Prior art keywords
- sup
- sub
- receptors
- indole derivatives
- relates
- Prior art date
Links
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title abstract 2
- 230000000561 anti-psychotic effect Effects 0.000 title 1
- 229940054051 antipsychotic indole derivative Drugs 0.000 title 1
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 2
- 102000015554 Dopamine receptor Human genes 0.000 abstract 1
- 108050004812 Dopamine receptor Proteins 0.000 abstract 1
- 125000000815 N-oxide group Chemical group 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960003638 dopamine Drugs 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000004031 partial agonist Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 230000000697 serotonin reuptake Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Light Guides In General And Applications Therefor (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2003/005789 WO2004106298A1 (en) | 2003-05-30 | 2003-05-30 | Indole derivatives with an improved antipsychotic activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE367392T1 true ATE367392T1 (de) | 2007-08-15 |
Family
ID=33483768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04741649T ATE367392T1 (de) | 2003-05-30 | 2004-05-26 | Indolderivate mit verbesserter antipsychotischer wirkung |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20070066608A1 (de) |
| JP (1) | JP2006528957A (de) |
| AT (1) | ATE367392T1 (de) |
| AU (1) | AU2004242802A1 (de) |
| CA (1) | CA2525282A1 (de) |
| DE (1) | DE602004007658T2 (de) |
| DK (1) | DK1636239T3 (de) |
| ES (1) | ES2289533T3 (de) |
| PT (1) | PT1636239E (de) |
| WO (2) | WO2004106298A1 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2364340T3 (es) | 2004-03-30 | 2011-08-31 | Vertex Pharmaceuticals Incorporated | Azaindoles útiles como inhibidores de jak y otras proteína quinasas. |
| JP4896476B2 (ja) * | 2005-09-16 | 2012-03-14 | 広栄化学工業株式会社 | メチルオキシメチルアミノピリジン誘導体及びその製造方法 |
| CN101678022A (zh) | 2006-12-21 | 2010-03-24 | 弗特克斯药品有限公司 | 可用作蛋白激酶抑制剂的5-氰基-4-(吡咯并[2,3b]吡啶-3-基)嘧啶衍生物 |
| GB0708186D0 (en) * | 2007-04-27 | 2007-06-06 | Merck Sharp & Dohme | Therapeutic compounds |
| MX2011006463A (es) | 2008-12-19 | 2011-07-20 | Supernus Pharmaceuticals Inc | Metodo de tratamiento de agresion. |
| LT3141252T (lt) | 2009-06-17 | 2018-11-12 | Vertex Pharmaceuticals Inc. | Gripo virusų replikacijos inhibitoriai |
| US8575186B2 (en) | 2009-10-05 | 2013-11-05 | Albany Molecular Research, Inc. | Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof |
| WO2011123497A1 (en) | 2010-03-31 | 2011-10-06 | Supernus Pharmaceuticals Inc. | Stabilized formulations of cns compounds |
| RU2013132681A (ru) | 2010-12-16 | 2015-01-27 | Вертекс Фармасьютикалз Инкорпорейтед | Ингибиторы репликации вирусов гриппа |
| EP2668191A4 (de) | 2011-01-19 | 2014-08-20 | Albany Molecular Res Inc | Benzofuro-[3,2-c-]pyridine und verwandte analoga als serotonin-untertyp-6 (5-ht6)-modulatoren zur behandlung von adipositas, stoffwechselsyndrom, kognition und schizophrenie |
| UA118010C2 (uk) | 2011-08-01 | 2018-11-12 | Вертекс Фармасьютікалз Інкорпорейтед | Інгібітори реплікації вірусів грипу |
| JP6618901B2 (ja) | 2013-11-13 | 2019-12-11 | バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ | インフルエンザウイルスの複製の阻害剤を調製する方法 |
| LT3068776T (lt) | 2013-11-13 | 2019-08-12 | Vertex Pharmaceuticals Incorporated | Gripo virusų replikacijos inhibitoriai |
| EP3294735B8 (de) | 2015-05-13 | 2022-01-05 | Vertex Pharmaceuticals Incorporated | Hemmer der influenzavirenreplikation |
| EP3294717B1 (de) | 2015-05-13 | 2020-07-29 | Vertex Pharmaceuticals Inc. | Verfahren zur herstellung von inhibitoren der influenzavirenreplikation |
| US11072602B2 (en) | 2016-12-06 | 2021-07-27 | Merck Sharp & Dohme Corp. | Antidiabetic heterocyclic compounds |
| BR112022015379A2 (pt) | 2020-02-04 | 2022-09-27 | Mindset Pharma Inc | Derivados de 3-pirrolidino-indol como agentes psicodélicos serotonérgicos para o tratamento de distúrbios do snc |
| WO2025085564A1 (en) * | 2023-10-16 | 2025-04-24 | Kronos Bio, Inc. | Lysine acetyltransferase inhibitors |
| WO2025104491A1 (en) | 2023-11-14 | 2025-05-22 | Mindset Pharma Inc. | Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2421900A1 (fr) * | 1977-03-17 | 1979-11-02 | Sauba Lab | Piperazino-3-indoles, leur procede de preparation et leurs applications therapeutiques |
| TW446706B (en) * | 1995-02-07 | 2001-07-21 | Janssen Pharmaceutica Nv | Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines, a pharmaceutical composition containing them, their intermediates and a process for their preparation |
| US6313126B1 (en) * | 1999-01-07 | 2001-11-06 | American Home Products Corp | Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
| AU2494300A (en) * | 1999-01-07 | 2000-07-24 | American Home Products Corporation | 3,4-dihydro-2h-benzo(1,4)oxazine derivatives |
| TW546299B (en) * | 1999-01-07 | 2003-08-11 | Wyeth Corp | 3,4-dihydro-2H-benzo[1,4]oxazinyl-methyl-[3-(1H-indol-3-yl)-alkyl]-amines |
| US6559169B2 (en) * | 2001-04-24 | 2003-05-06 | Wyeth | Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-benzodioxan |
| US6656950B2 (en) * | 2001-04-25 | 2003-12-02 | Wyeth | Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine |
-
2003
- 2003-05-30 WO PCT/EP2003/005789 patent/WO2004106298A1/en not_active Ceased
-
2004
- 2004-05-26 CA CA002525282A patent/CA2525282A1/en not_active Abandoned
- 2004-05-26 WO PCT/EP2004/050922 patent/WO2004106346A1/en not_active Ceased
- 2004-05-26 PT PT04741649T patent/PT1636239E/pt unknown
- 2004-05-26 JP JP2006530219A patent/JP2006528957A/ja not_active Withdrawn
- 2004-05-26 DK DK04741649T patent/DK1636239T3/da active
- 2004-05-26 AU AU2004242802A patent/AU2004242802A1/en not_active Abandoned
- 2004-05-26 ES ES04741649T patent/ES2289533T3/es not_active Expired - Lifetime
- 2004-05-26 US US10/556,931 patent/US20070066608A1/en not_active Abandoned
- 2004-05-26 DE DE602004007658T patent/DE602004007658T2/de not_active Expired - Fee Related
- 2004-05-26 AT AT04741649T patent/ATE367392T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006528957A (ja) | 2006-12-28 |
| WO2004106346A1 (en) | 2004-12-09 |
| CA2525282A1 (en) | 2004-12-09 |
| ES2289533T3 (es) | 2008-02-01 |
| US20070066608A1 (en) | 2007-03-22 |
| DE602004007658D1 (de) | 2007-08-30 |
| DE602004007658T2 (de) | 2008-04-10 |
| DK1636239T3 (da) | 2007-10-29 |
| AU2004242802A1 (en) | 2004-12-09 |
| PT1636239E (pt) | 2007-09-24 |
| WO2004106298A1 (en) | 2004-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE367392T1 (de) | Indolderivate mit verbesserter antipsychotischer wirkung | |
| MX2007012883A (es) | Derivados de dihidrobenzofurano y usos de los mismos. | |
| MX2007012936A (es) | Derivados de dihidrobenzofurano y usos de los mismos. | |
| MX2007013021A (es) | Derivados de benzofuranil-alcanamina y usos de los mismos como agonistas de 5-ht2c. | |
| WO2006079637A8 (en) | Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders | |
| EA200300519A1 (ru) | Соединения производных бензотиофена, способ их получения и применения | |
| IL177291A0 (en) | Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists | |
| MY125295A (en) | 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives | |
| WO2007088276A3 (fr) | Derives de sulfonamides, leur preparation et leur application en therapeutique | |
| NO20025640D0 (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister | |
| ATE318266T1 (de) | 3-substituierte chinolin-4- carbonsäureamidderivate als nk-3- und nk-2- rezeptorantagonisten | |
| EA200501148A1 (ru) | Пиридилоксиметильные и бензизоксазольные азабициклические производные | |
| ATE475640T1 (de) | Antagonisten des opioidrezeptors | |
| WO2006061392A3 (en) | Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives | |
| MXPA05010483A (es) | Cromenonindoles. | |
| ATE443707T1 (de) | Isoxazolin-indol-derivate mit verbesserter antipsychotischer und anxiolytischer aktivität | |
| MY123686A (en) | Indole derivatives and their use as 5ht2a ligands | |
| DE602004016177D1 (de) | Methylindole und methylpyrrolopyridine als alpha-1-adrenerge agonisten | |
| TW200612899A (en) | Novel tetracyclic tetrahydrofuran derivatives | |
| ATE337781T1 (de) | Pyridinalykl-aminoalkyl-1h-indol derivate mit hemmender wirkung auf die 5-ht und serotonin wiederaufnahme als antidepressiva und anxiolytika | |
| WO2002066473A8 (en) | 8’4-’3-(5-fluoro-1h-indol-3yl) propyl!-1-piperazynyl!-2-methyl-2h-1,4-benzoxazin -3 (4h)- one methanesulfonate with high affinity for the dopamine d 2 receptor and the serotonin reuptake site | |
| EA200702626A1 (ru) | Новые замещённые тетрациклические производные тетрагидрофурана, пирролидина и тетрагидротиофена и их применение в качестве лекарственного средства | |
| WO2006000555A3 (en) | Novel unsaturated tetracyclic tetrahydrofuran derivatives | |
| ATE460411T1 (de) | Neue tetracyclische tetrahydrofuran-derivate mit cyclischer aminseitenkette | |
| EA200702530A1 (ru) | Некоторые тетрациклические производные тетрагидрофурана, содержащие в боковой цепи циклическую аминогруппу |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1636239 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |